This site is intended for healthcare professionals
News

Breztri Aerosphere significantly reduced rate of moderate or severe COPD exacerbations in phase III ETHOS trial.- AstraZeneca

Read time: 1 mins
Last updated:25th Jun 2020
Published:25th Jun 2020
Condition: Chronic Obstructive Pulmonary Disease
Type: drug
Register free for full access to medthority.com